Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: Maintenance of tight latency with efficient reactivation upon induction

Journal of Virological Methods

Volumn 174, Issue 1-2, 2011, Pages 12-21

  Myoung, Jinjong ^a   Ganem, Don ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Herpesvirus; Kaposi's sarcoma; Latency; Reactivation

Indexed keywords

BUTYRIC ACID; DOXYCYCLINE; PUROMYCIN; VALPROIC ACID;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOLOGY; ENDOTHELIUM CELL; HOST CELL; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; VERO CELL; VIRAL PHENOMENA AND FUNCTIONS; VIROLYSIS; VIRUS INDUCTION; VIRUS INFECTIVITY; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION;

ANIMALS; CELL LINE; DOXYCYCLINE; GENE EXPRESSION REGULATION; HERPESVIRUS 8, HUMAN; HUMANS; VIRUS ACTIVATION; VIRUS CULTIVATION; VIRUS LATENCY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

EID: 79955754014     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.03.012     Document Type: Article

References (34)

1. Alt F.W., Kellems R.E., Bertino J.R., Schimke R.T. Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. J. Biol. Chem. 1978, 253:1357-1370.
2. Bechtel J.T., Liang Y., Hvidding J., Ganem D. Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells. J. Virol. 2003, 77:6474-6481.
3. Chandran B. Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells. J. Virol. 2009, 84:2188-2199.
4. Chandriani S., Xu Y., Ganem D. The lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes. J. Virol. 2010, 84:7934-7942.
5. Chen J., Ueda K., Sakakibara S., Okuno T., Parravicini C., Corbellino M., Yamanishi K. Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:4119-4124.
6. Chen J., Ueda K., Sakakibara S., Okuno T., Yamanishi K. Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene. J. Virol. 2000, 74:8623-8634.
7. Deng H., Chu J.T., Rettig M.B., Martinez-Maza O., Sun R. Rta of the human herpesvirus 8/Kaposi sarcoma-associated herpesvirus up-regulates human interleukin-6 gene expression. Blood 2002, 100:1919-1921.
8. Dittmer D., Stoddart C., Renne R., Linquist-Stepps V., Moreno M.E., Bare C., McCune J.M., Ganem D. Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice. J. Exp. Med. 1999, 190:1857-1868.
9. Ganem D. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J. Clin. Invest. 2010, 120:939-949.
10. Hutt-Fletcher L.M. Epstein-Barr virus entry. J. Virol. 2007, 81:7825-7832.
11. Kaufman R.J., Bertino J.R., Schimke R.T. Quantitation of dihydrofolate reductase in individual parental and methotrexate-resistant murine cells. Use of a fluorescence activated cell sorter. J. Biol. Chem. 1978, 253:5852-5860.
12. Kozak M. Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin in vivo. Nature 1984, 308:241-246.
13. Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 1986, 44:283-292.
14. Kozak M. An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 1987, 15:8125-8148.
15. Liang Y., Chang J., Lynch S.J., Lukac D.M., Ganem D. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev. 2002, 16:1977-1989.
16. Liang Y., Ganem D. RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA. J. Virol. 2004, 78:6818-6826.
17. Lukac D.M., Garibyan L., Kirshner J.R., Palmeri D., Ganem D. DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters. J. Virol. 2001, 75:6786-6799.
18. Lukac D.M., Kirshner J.R., Ganem D. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J. Virol. 1999, 73:9348-9361.
19. Lukac D.M., Renne R., Kirshner J.R., Ganem D. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 1998, 252:304-312.
20. Miller G., Heston L., Grogan E., Gradoville L., Rigsby M., Sun R., Shedd D., Kushnaryov V.M., Grossberg S., Chang Y. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J. Virol. 1997, 71:314-324.
21. Myoung J., Ganem D. Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells. J. Clin. Invest. 2011.
22. Myoung J., Ganem D. Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells. Virology 2011.
23. Nakamura H., Lu M., Gwack Y., Souvlis J., Zeichner S.L., Jung J.U. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J. Virol. 2003, 77:4205-4220.
24. Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D., Ganem D. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 1996, 2:342-346.
25. Sadler R., Wu L., Forghani B., Renne R., Zhong W., Herndier B., Ganem D. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J. Virol. 1999, 73:5722-5730.
26. Schimke R.T., Alt F.W., Kellems R.E., Kaufman R.J., Bertino J.R. Amplification of dihydrofolate reductase genes in methotrexate-resistant cultured mouse cells. Cold Spring Harb. Symp. Quant. Biol. 1978, 42(Pt. 2):649-657.
27. Shaw R.N., Arbiser J.L., Offermann M.K. Valproic acid induces human herpesvirus 8 lytic gene expression in BCBL-1 cells. AIDS 2000, 14:899-902.
28. Siegal B., Levinton-Kriss S., Schiffer A., Sayar J., Engelberg I., Vonsover A., Ramon Y., Rubinstein E. Kaposi's sarcoma in immunosuppression. Possibly the result of a dual viral infection. Cancer 1990, 65:492-498.
29. Song M.J., Brown H.J., Wu T.T., Sun R. Transcription activation of polyadenylated nuclear rna by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus. J. Virol. 2001, 75:3129-3140.
30. Sun R., Lin S.F., Gradoville L., Yuan Y., Zhu F., Miller G. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:10866-10871.
31. Vieira J., O'Hearn P.M. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 2004, 325:225-240.
32. Vieira J., O'Hearn P., Kimball L., Chandran B., Corey L. Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J. Virol. 2001, 75:1378-1386.
33. Xu Y., AuCoin D.P., Huete A.R., Cei S.A., Hanson L.J., Pari G.S. A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication. J. Virol. 2005, 79:3479-3487.
34. Yoo S.M., Ahn A.K., Seo T., Hong H.B., Chung M.A., Jung S.D., Cho H., Lee M.S. Centrifugal enhancement of Kaposi's sarcoma-associated virus infection of human endothelial cells in vitro. J. Virol. Methods 2008, 154:160-166.